Apotea (APOTEA) Stock Overview
Operates an online pharmacy in Sweden. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for APOTEA from our risk checks.
APOTEA Community Fair Values
Create NarrativeSee what 23 others think this stock is worth. Follow their fair value or set your own to get alerts.
Apotea AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 87.96 |
| 52 Week High | SEK 122.00 |
| 52 Week Low | SEK 66.31 |
| Beta | 0 |
| 1 Month Change | -6.99% |
| 3 Month Change | -21.23% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 4.71% |
Recent News & Updates
Recent updates
Apotea AB (publ) (STO:APOTEA) Shares Could Be 45% Below Their Intrinsic Value Estimate
Jul 17
Apotea is poised for growth with its online pharmacy dominance and upcoming market expansions
Online Pharmacy Market Growth: The Swedish pharmacy market is shifting online, benefiting Apotea as the dominant e-commerce player. Consumers increasingly prefer digital purchases over physical storeShareholder Returns
| APOTEA | SE Consumer Retailing | SE Market | |
|---|---|---|---|
| 7D | 1.7% | -2.0% | 0.7% |
| 1Y | n/a | 6.7% | 4.2% |
Return vs Industry: Insufficient data to determine how APOTEA performed against the Swedish Consumer Retailing industry.
Return vs Market: Insufficient data to determine how APOTEA performed against the Swedish Market.
Price Volatility
| APOTEA volatility | |
|---|---|
| APOTEA Average Weekly Movement | 4.8% |
| Consumer Retailing Industry Average Movement | 3.7% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in SE Market | 11.9% |
| 10% least volatile stocks in SE Market | 3.1% |
Stable Share Price: APOTEA has not had significant price volatility in the past 3 months compared to the Swedish market.
Volatility Over Time: APOTEA's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 724 | Par Svardson | www.apotea.se |
Apotea AB (publ) operates an online pharmacy in Sweden. It offers products in the areas of allergy, face, child and parent, bite and sting, preparedness, animal, fever and aches, cold, home and household, aid, hair removal and shaving, hair care, hands and feet, intimate, dietary supplements, body care, stomach and intestine, food and beverage, mouth and teeth, toiletries, travel packaging and accessories, sex and lust, stop smoking, makeup, sun protection, wounds and injuries, sleep and sleep problems, training, weight control, vitamins and minerals, and eyes and ears. The company was founded in 2011 and is headquartered in Stockholm, Sweden.
Apotea AB (publ) Fundamentals Summary
| APOTEA fundamental statistics | |
|---|---|
| Market cap | SEK 9.15b |
| Earnings (TTM) | SEK 262.80m |
| Revenue (TTM) | SEK 7.09b |
Is APOTEA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| APOTEA income statement (TTM) | |
|---|---|
| Revenue | SEK 7.09b |
| Cost of Revenue | SEK 5.13b |
| Gross Profit | SEK 1.96b |
| Other Expenses | SEK 1.69b |
| Earnings | SEK 262.80m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
Feb 04, 2026
| Earnings per share (EPS) | 2.53 |
| Gross Margin | 27.60% |
| Net Profit Margin | 3.71% |
| Debt/Equity Ratio | 0% |
How did APOTEA perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/15 17:09 |
| End of Day Share Price | 2025/11/14 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Apotea AB (publ) is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | ABG Sundal Collier |
| Niklas Ekman | DNB Carnegie |